Xamoterol

Xamoterol
Clinical data
ATC code	C01CX07 (WHO) ;
Identifiers
	IUPAC name (RS)-N-(2-{[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino}ethyl)morpholine-4-carboxamide;
CAS Number	81801-12-9 ;
PubChem CID	155774;
IUPHAR/BPS	538;
ChemSpider	137213 ;
UNII	7HE0JQL703;
KEGG	D06328 ;
ChEMBL	ChEMBL75753 ;
CompTox Dashboard (EPA)	DTXSID8045222 ;
Chemical and physical data
Formula	C16H25N3O5
Molar mass	339.392 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(NCCNCC(O)COc1ccc(O)cc1)N2CCOCC2;
	InChI InChI=1S/C16H25N3O5/c20-13-1-3-15(4-2-13)24-12-14(21)11-17-5-6-18-16(22)19-7-9-23-10-8-19/h1-4,14,17,20-21H,5-12H2,(H,18,22) ; Key:DXPOSRCHIDYWHW-UHFFFAOYSA-N ;
	(what is this?) (verify)

Xamoterol is a cardiac stimulant. It works by binding to the β₁ adrenergic receptor. It is a 3rd generation adrenergic β receptor partial agonist.^[1] It provides cardiac stimulation at rest but it acts as a blocker during exercise.^[2]

References

↑ Marlow HF (1989). "Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure". British Journal of Clinical Pharmacology. 28 (Suppl 1): 23S–30S. doi:10.1111/j.1365-2125.1989.tb03570.x. PMC 1379873. PMID 2572251.
↑ Rang HP, Dale MM, Ritter JM, Moore PK (1999). Pharmacology (5th ed.). Edinburgh; New York: Churchill Livingstone. p. 163. ISBN 0443059748.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.